Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/91709
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review protocol |
Author: | Dabrow Woods, A. Giometti, R. Weeks, S. |
Citation: | The JBI Database of Systematic Reviews and Implementation Reports, 2014; 12(1):74-89 |
Publisher: | Joanna Briggs Institute |
Issue Date: | 2014 |
ISSN: | 2202-4433 2202-4433 |
Statement of Responsibility: | Anne Dabrow Woods, Renee Giometti, Susan Weeks |
Abstract: | Review question/objective - In adult intensive care unit patients experiencing alcohol withdrawal, does the use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy decrease delirium severity more effectively than benzodiazepine-based therapy alone? The objective of the systematic review is to examine the best available evidence of the clinical effectiveness of dexmedetomidine as an adjuvant to benzodiazepine-based therapy versus benzodiazepine-based therapy alone, in decreasing delirium severity associated with alcohol withdrawal in adult intensive care unit patients over the age of 18 years. |
Keywords: | alcohol withdrawal syndrome; benzodiazepine-based therapy; delirium; dexmedetomidine; intensive care unit |
Rights: | Copyright status unknown |
DOI: | 10.11124/jbisrir-2014-1285 |
Published version: | http://dx.doi.org/10.11124/jbisrir-2014-1285 |
Appears in Collections: | Aurora harvest 2 Translational Health Science publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.